Home » Newsletters » BioWorld Science

BioWorld Science

March 31, 2011

View Archived Issues

Merck & Co. presents new glucagon receptor antagonist for type 2 diabetes

Betulin shows potential for the treatment of metabolic syndrome

Bellicum granted award to support CaspaCIDe cancer therapy

New dual LFA-1/MAC-1 antagonists presented by Roche at the ACS meeting

Dainippon Sumitomo and Intercept sign licensing agreement for obeticholic acid

OriBase Pharma identifies agent for BCR/ABL T315I mutant CML

Cellzome patents new series of compounds that inhibit JAK3

SMO inhibitors reported by Pfizer for use in cancer

New steroid sulfatase/aromatase inhibitors reported by Sterix

Ark Therapeutics presents new neuropilin-1 antagonists

PHOENIX trial of PHP in distributive shock to continue after interim analysis

European Commission approves retigabine for partial onset seizures

ViroPharma begins phase II Cinryze study for antibody-mediated rejection

Gilead Sciences and Yale to collaborate on cancer research

Phase IIb trial of Pharmasset's PSI-7977 for multiple HCV genotypes begins

Phase II trial compares MDV-3100 with bicalutamide in advanced prostate cancer

Valeant Pharmaceuticals proposes to acquire Cephalon

Merck Serono applies for E.U. indication extension for Erbitux for advanced or metastatic NSCLC

Dainippon Sumitomo and Takeda sign agreement for lurasidone in Europe

Natco Pharma receives FDA orphan drug status for NRC-AN-019

Amgen and Takeda report topline phase II results for motesanib in lung cancer

U.S. Department of Defense and Cytos Biotechnology collaborate on malaria vaccines research

Eli Lilly launches Axiron topical testosterone replacement therapy in the U.S.

Alzheimer's Drug Discovery Foundation to fund Prana's PBT-2 phase II trial

Composite iMyD88/CD40 fusion protein shows enhanced antitumor activity

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...